Metabolic reprogramming in osteoclasts
نویسندگان
چکیده
منابع مشابه
Metabolic Reprogramming in Glioma
Many cancers have long been thought to primarily metabolize glucose for energy production-a phenomenon known as the Warburg Effect, after the classic studies of Otto Warburg in the early twentieth century. Yet cancer cells also utilize other substrates, such as amino acids and fatty acids, to produce raw materials for cellular maintenance and energetic currency to accomplish cellular tasks. The...
متن کاملMetabolic Reprogramming in Thyroid Carcinoma
Among all the adaptations of cancer cells, their ability to change metabolism from the oxidative to the glycolytic phenotype is a hallmark called the Warburg effect. Studies on tumor metabolism show that improved glycolysis and glutaminolysis are necessary to maintain rapid cell proliferation, tumor progression, and resistance to cell death. Thyroid neoplasms are common endocrine tumors that ar...
متن کاملMetabolic reprogramming by KSHV in cellular transformation
Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) is causally linked to several human cancers including Kaposi’s sarcoma and primary effusion lymphoma. Despite intensive studies, little is known about how KSHV alters cellular metabolism during cellular transformation. Using a novel model of KSHV-induced cellular transformation of primary rat embryonic metanephric mesenchymal stem cells (...
متن کاملMetabolic Reprogramming in Mutant IDH1 Glioma Cells
BACKGROUND Mutations in isocitrate dehydrogenase (IDH) 1 have been reported in over 70% of low-grade gliomas and secondary glioblastomas. IDH1 is the enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate while mutant IDH1 catalyzes the conversion of α-ketoglutarate into 2-hydroxyglutarate. These mutations are associated with the accumulation of 2-hydroxyglutarate ...
متن کاملMetabolic Reprogramming During Multidrug Resistance in Leukemias
Cancer outcome has improved since introduction of target therapy. However, treatment success is still impaired by the same drug resistance mechanism of classical chemotherapy, known as multidrug resistance (MDR) phenotype. This phenotype promotes resistance to drugs with different structures and mechanism of action. Recent reports have shown that resistance acquisition is coupled to metabolic r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Immunopathology
سال: 2019
ISSN: 1863-2297,1863-2300
DOI: 10.1007/s00281-019-00757-0